Stocks mixed; COVID-19 vaccine trials to restart
Embed this video
Share
Description
Wall Street closed narrowly mixed without an economic stimulus agreement in Washington. AstraZeneca and Johnson & Johnson both got the green light to restart U.S. clinical trials for the experimental COVID-19 vaccines. Conway G. Gittens has all the details.
General Info
UploadedOct 23, 2020
watch more videos